nad+
NAD+, made easy.
NAD+ is a core cellular coenzyme involved in energy metabolism and DNA repair, and it appears frequently in longevity research discussions. This page is a neutral overview of what it is, how it works, and where the science currently stands.
Educational only — not medical advice. Consult a qualified licensed provider.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell — not a peptide. It carries electrons for energy metabolism and is consumed by DNA-repair enzymes and sirtuins. Tissue levels are observed to decline with age, which is why it is discussed in longevity research, often in the context of precursors like NR or NMN. This page is educational background only — not medical advice.
What NAD+ is
First, an honest framing: NAD+ is not a peptide. It is a coenzyme — a single molecule that pairs a nicotinamide unit with an adenine unit into one dinucleotide — and it is covered here because it appears constantly inside longevity and 'peptide stack' culture, alongside the actual peptides people discuss. Biologically, NAD+ (nicotinamide adenine dinucleotide) is about as foundational as cell chemistry gets. It works as a redox partner, ferrying electrons through the reactions that generate energy, and it acts as raw material that certain enzymes consume to do their jobs. Because cells do not absorb NAD+ itself very well from the outside, research on raising NAD+ typically focuses on precursors — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). One point worth holding onto: studies show blood NAD+ can be raised, but raising the number is not the same as a proven anti-aging effect.
How NAD+ works
NAD+ plays three well-established roles in cells. As a redox cofactor, the NAD+/NADH pair shuttles electrons through glycolysis, the citric-acid cycle, and oxidative phosphorylation — the machinery that produces ATP, the cell's energy currency. As a substrate, it is consumed by sirtuins, a family of enzymes tied to stress resistance and the metabolic changes seen with calorie restriction in lab organisms. And it feeds PARP enzymes, which repair damaged DNA. Tissue NAD+ is observed to decline with age, and that decline is the entire reason it became a research topic — the question being whether restoring it changes anything functional. The biochemistry here is solid. What is genuinely unresolved is the leap from 'NAD+ went up' to 'aging slowed down' in humans. Several human trials confirm precursors elevate NAD+ yet do not reproduce the dramatic effects seen in animals, so the mechanism is well understood while the longevity payoff remains unproven.
Areas of research interest
- Longevity and healthy-aging biology — the area NAD+ is most associated with, though human lifespan benefit is not established
- Energy and mitochondrial metabolism — studied because of NAD+'s role in ATP production
- Metabolic measures such as glucose handling — investigated in humans with mixed and often null results
- Specific conditions such as Parkinson's, peripheral artery disease, and prediabetes — explored only in small, preliminary trials, none confirmatory
- Mechanistic work on sirtuin and PARP enzyme activity, where NAD+ acts as a required substrate
Regulatory & legal status
NAD+ is not an FDA-approved drug for anti-aging or any longevity indication. Nicotinamide riboside (NR) is sold as a dietary supplement; as of September 2025 the FDA reversed its earlier 2022 position and stated NMN is lawful in US supplements, though NMN still counts as a New Dietary Ingredient subject to premarket notification. IV NAD+ is provided through clinics and compounding, not as an approved therapy. None of this is medical advice — anyone considering NAD+ or its precursors should consult a qualified licensed provider about their own situation.
NAD+ vs SS-31 vs MOTS-c
| NAD+ | SS-31 | MOTS-c | |
|---|---|---|---|
| What it is | Coenzyme / supplement (not a peptide) | Targeted peptide | Mitochondrial-derived peptide |
| Research framing | Energy, longevity, anti-aging | Mitochondrial / energy support | Metabolic / energy signaling |
| How it acts | Redox cofactor + sirtuin/PARP substrate | Targets mitochondrial membrane | Signals through AMPK |
| Status | Precursors sold as supplements; NAD+ itself research-grade | Investigational; not FDA-approved | Research-grade peptide |
Frequently asked
What adverse effects have been reported for NAD+?+
In published research, oral precursors (NR/NMN) have been associated with mild gastrointestinal upset or flushing. Rapid IV NAD+ infusion has been reported in case literature alongside chest tightness, nausea, flushing, and cramping, and very high niacin-type intake has been associated with changes in liver enzymes. This is a neutral summary of reported observations, not medical advice — anyone with questions about their own situation should consult a qualified licensed provider.
Is NAD+ a steroid or a peptide?+
Neither. NAD+ is a coenzyme — a dinucleotide cells use for energy metabolism and repair. It is not an anabolic steroid and not a peptide; it appears on peptide-focused sites only because it is ubiquitous in longevity and peptide-stack culture.
Is NAD+ FDA approved?+
NAD+ is not an FDA-approved drug for anti-aging. NR is sold as a dietary supplement, and as of September 2025 the FDA stated NMN is lawful in US supplements (reversing its 2022 position), though NMN remains a New Dietary Ingredient requiring premarket notification. IV NAD+ is given through clinics, not as an approved therapy.
Does raising NAD+ slow aging in humans?+
Studies confirm precursors like NR and NMN can raise blood NAD+, but there is no definitive human evidence that doing so extends lifespan or reverses aging, despite promising animal data. The mechanism is well characterized; the longevity outcome is unproven. This is educational background, not medical advice.
Everything peptides, made easy.
Join PepEasy and get the tools, the knowledge, and the care — in one place.
Explore more